The Resident Evil box office story has taken a turn few earlier installments could match. For years, these films relied heavily on international audiences to build their worldwide totals. Now, Zach Cregger’s new adaptation has achieved something different: a North American breakthrough alongside its global success.
According to the latest figures reported by Variety, the Sony Pictures release has reached approximately $400 million worldwide. That makes it the highest-grossing Resident Evil film to date. Yet the most interesting achievement is not simply the record itself. It is how differently this installment has performed compared with its predecessors.
Why the Resident Evil box office record is different this time
Previous Resident Evil films could generate impressive worldwide earnings without becoming enormous domestic hits. The clearest example is Resident Evil: The Final Chapter, released in 2016. Despite earning approximately $314 million globally, it collected only around $26.8 million in the United States and Canada.
Resident Evil: Afterlife followed a similar pattern in 2010. Its worldwide total approached $296 million, while North American earnings finished at approximately $60.1 million. International markets were essential to both films.
Cregger’s version has changed that balance. Its reported North American total now stands at $157.4 million, more than two and a half times the previous franchise high. International audiences have contributed another $242.6 million, accounting for roughly 61% of the reported worldwide total.
That distinction matters. This is not merely another Resident Evil movie performing well overseas. For the first time, the franchise has demonstrated a substantially larger theatrical audience in its domestic market.
A $60 million opening changed the franchise’s expectations
The first warning that this release might outperform its predecessors arrived during September 18-20, 2026. Resident Evil opened with approximately $60.2 million in North America, establishing a new franchise opening-weekend record.
Its worldwide debut reached around $108.3 million. Consequently, the film entered its theatrical run with momentum that earlier installments had struggled to generate domestically.
The comparison becomes even more striking when looking at the entire series. No previous Resident Evil film had passed $100 million in North America across its complete theatrical run. Cregger’s adaptation crossed that barrier and continued climbing.
Furthermore, its performance suggests that the brand attracted audiences beyond the level historically associated with these adaptations. The numbers cannot establish exactly how many newcomers bought tickets. Nevertheless, they demonstrate a significantly larger domestic theatrical reach.
Zach Cregger reaches a new milestone after Weapons
The commercial result also changes the picture for director Zach Cregger. Following Barbarian and Weapons, he entered Resident Evil with an established reputation for horror filmmaking.
Weapons, released in 2025, earned approximately $270 million worldwide. His latest project has now comfortably surpassed that figure, becoming the biggest box office success of his directing career.
There is another important distinction. Resident Evil carries the expectations of an established video game franchise, whereas Cregger’s earlier horror work helped build his reputation through original storytelling.
Working with a familiar property brings immediate recognition, but also invites comparisons with earlier adaptations and beloved games. The new film’s financial performance suggests that this combination of recognizable intellectual property and a director with a distinct horror background can reach a considerable audience.
According to The Numbers’ financial breakdown, production cost approximately $75 million. The reported worldwide gross is therefore more than five times that estimated production budget.
However, theatrical revenue should not be confused with studio profit. Cinemas retain part of ticket sales, while marketing and distribution introduce additional expenses. Even so, the scale of this theatrical performance is an important commercial achievement.
Why 2026 has become a turning point for Resident Evil
The timing makes this achievement particularly interesting for Capcom’s long-running horror franchise. Resident Evil Requiem launched on February 27, 2026, giving the gaming series another major release earlier in the year.
Several months later, the film brought the same recognizable universe back into cinemas. Although these are separate projects, their arrival within one calendar year has kept Resident Evil visible across two entertainment markets.
This also comes during a period when video game adaptations have become an increasingly important part of Hollywood’s release strategy. However, success is never automatic. Familiar characters, monsters, or franchise names alone cannot guarantee that audiences will support a theatrical release.
For players following the growing relationship between gaming and cinema, Battle4Play also examines Sony’s upcoming Mouthwashing movie adaptation, another horror project facing the challenge of translating a distinctive video game experience to the big screen.
Importantly, the film’s performance does not mean another Resident Evil movie has been approved. No sequel has been officially announced, and any discussion of a follow-up remains speculative.
Nevertheless, Sony and the companies involved now have a considerably stronger theatrical benchmark when evaluating the franchise’s future.
The Resident Evil box office achievement is ultimately about more than overtaking an old record. It demonstrates that the series can perform at a different scale in North America while retaining substantial international appeal.
After such a significant year for Resident Evil, the question is no longer whether the brand can attract moviegoers. It is whether a future adaptation could maintain this momentum without losing the horror identity that made the games famous.





